Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Results of a Phase 1 Trial of Gda-201, Nicotinamide-Expanded Allogeneic Natural Killer Cells (NAM-NK) in Patients with Refractory Non-Hodgkin Lymphoma (NHL) and Multiple Myeloma (MM)

Veronika Bachanova, MD PhD, David H. McKenna, MD, Xianghua Luo, PhD, Todd E. DeFor, MS, Fiona He, MD, Murali Janakiram, MD MS, Erica D. Warlick, MD, Rose Wangen, Zuzan Cayci, MD, Bartosz Grzywacz, MD, Guy Brachya, PhD, Tony Peled, MSc, Jeffrey S. Miller, MD

Blood (2019) 134 (Supplement_1): 777.

https://doi.org/10.1182/blood-2019-130476

Published: 2019

Journal Articles

Immune Reconstitution (IR) after Allogeneic Hematopoietic Cell Transplantation (alloHCT): Comparing Results in Recipients of Unrelated Umbilical Cord Blood (UCB) to Those with an HLA-Matched Sibling Donor Peripheral Blood (MSD PB)

Nelli Bejanyan, MD, Claudio G Brunstein, MD, Qing Cao, M.S., Rohtesh S. Mehta, MD MPH, MS, Xianghua Luo, PhD, Julie Curtsinger, PhD, Sarah Cooley, MD, Bruce R. Blazar, MD, Jeffrey S. Miller, MD, Daniel Weisdorf, MD, John E. Wagner, MD, Michael R. Verneris, MD

Blood (2016) 128 (22): 4590.

https://doi.org/10.1182/blood.V128.22.4590.4590

Published: 2016

Journal Articles

Immune Reconstitution after Umbilical Cord Blood Versus Peripheral Blood Progenitor Cell Transplantation in Adults Following Myeloablative Conditioning

Rohtesh S. Mehta, MD MPH, MS, Nelli Bejanyan, MD, Qing Cao, M.S., Xianghua Luo, PhD, Claudio Brunstein, Sarah Cooley, MD, Bruce R. Blazar, MD, Daniel J. Weisdorf, MD, John E. Wagner, MD, Jeffrey S. Miller, MD, Michael R. Verneris, MD

Blood (2016) 128 (22): 2246.

https://doi.org/10.1182/blood.V128.22.2246.2246

Published: 2016

Journal Articles

Adaptive NK Cell Expansion Is Associated with Reduced Relapse of Lymphoid Malignancies after Autologous Hematopoietic Cell Transplant

Rohtesh S. Mehta, MD MPH, MS, Rose Wangen, Frank Cichocki, PhD, Martin Felices, PhD, Xianghua Luo, PhD, Daniel J. Weisdorf, MD, Michael R. Verneris, MD, Jeffrey S. Miller, MD, Sarah Cooley, MD

Blood (2016) 128 (22): 515.

https://doi.org/10.1182/blood.V128.22.515.515

Published: 2016

Journal Articles

Defining Successful Immune Reconstitution (IR) after Allogeneic Hematopoietic Cell Transplantation (HCT)

Mayada Salman Abu Shanap, MD, Sarah Cooley, MD, Xianghua Luo, PhD, Cao Qing, Julie Curtsinger, PhD, Rachel Bergerson, PhD, Nelli Bejanyan, Heather Stefanski, MD PhD, Claudio Brunstein, MD, Daniel J. Weisdorf, MD, Bruce R. Blazar, MD, Jeffrey S. Miller, MD, John E Wagner, MD, Michael R. Verneris, MD

Blood (2015) 126 (23): 1934.

https://doi.org/10.1182/blood.V126.23.1934.1934

Published: 2015

Journal Articles

Pharmacogenetics of Mycophenolate Mofetil in Patients Undergoing Hematopoietic Cell Transplantation (HCT).

Janel Long, PharmD, William S. Oetting, PhD, Wang Xinjing, MD, PhD, Xianghua Luo, PhD, Marcie Tomblyn, MD, Daniel Weisdorf, MD, Pamala Jacobson, PharmD

Blood (2007) 110 (11): 3010.

https://doi.org/10.1182/blood.V110.11.3010.3010

Published: 2007

Journal Articles

Hematopoietic Cell Transplantation as Therapy for Pediatric Patients with Relapsed Acute Lymphoblastic Leukemia with and without CNS Involvement.

Paul D. Harker-Murray, MD, PhD, Michael R. Verneris, MD, Avis J. Thomas, MS, Xianghua Luo, PhD, Margaret L. MacMillan, MD, Jakub Tolar, MD, PhD, K. Scott Baker, MD, MS, John E. Wagner, MD, Paul J. Orchard, MD

Blood (2006) 108 (11): 3110.

https://doi.org/10.1182/blood.V108.11.3110.3110

Published: 2006

Journal Articles

Promising Progression Free and Overall Survival Using a Novel (CY/FLU/TBI) Reduced-Intensity Conditioning (RIC) Regimen for Allogeneic Sibling Stem Cell Transplantation (SCT).

Marcie Tomblyn, MD, MS, Jeffrey S. Miller, MD, Linda J. Burns, MD, Bruce R. Blazar, MD, PhD, Mukta Arora, MD, MS, Xianghua Luo, PhD, Todd Defor, MS, Claudio Brunstein, MD, PhD, Kathryn Dusenbery, MD, Margaret L. MacMillan, MD, Michael Verneris, MD, PhD, John Wagner, MD, Daniel J. Weisdorf, MD

Blood (2006) 108 (11): 2999.

https://doi.org/10.1182/blood.V108.11.2999.2999

Published: 2006

NARROW

Results of a Phase 1 Trial of Gda-201, Nicotinamide-Expanded Allogeneic Natural Killer Cells (NAM-NK) in Patients with Refractory Non-Hodgkin Lymphoma (NHL) and Multiple Myeloma (MM)

Immune Reconstitution (IR) after Allogeneic Hematopoietic Cell Transplantation (alloHCT): Comparing Results in Recipients of Unrelated Umbilical Cord Blood (UCB) to Those with an HLA-Matched Sibling Donor Peripheral Blood (MSD PB)

Immune Reconstitution after Umbilical Cord Blood Versus Peripheral Blood Progenitor Cell Transplantation in Adults Following Myeloablative Conditioning

Adaptive NK Cell Expansion Is Associated with Reduced Relapse of Lymphoid Malignancies after Autologous Hematopoietic Cell Transplant

Defining Successful Immune Reconstitution (IR) after Allogeneic Hematopoietic Cell Transplantation (HCT)

Pharmacogenetics of Mycophenolate Mofetil in Patients Undergoing Hematopoietic Cell Transplantation (HCT).

Hematopoietic Cell Transplantation as Therapy for Pediatric Patients with Relapsed Acute Lymphoblastic Leukemia with and without CNS Involvement.

Promising Progression Free and Overall Survival Using a Novel (CY/FLU/TBI) Reduced-Intensity Conditioning (RIC) Regimen for Allogeneic Sibling Stem Cell Transplantation (SCT).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only